{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:28:17Z","timestamp":1785472097796,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["DK-107870"],"award-info":[{"award-number":["DK-107870"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["HL098967"],"award-info":[{"award-number":["HL098967"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.trsl.2021.03.005","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T20:49:02Z","timestamp":1615322942000},"page":"32-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Identification of novel therapeutic targets for contrast induced acute kidney injury (CI-AKI): alpha blockers as a therapeutic strategy for CI-AKI"],"prefix":"10.1016","volume":"235","author":[{"given":"Sreenivasulu","family":"Kilari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishek","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanqi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Simeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre J.","family":"van Wijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2021.03.005_bib0001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1051-0443(07)61394-3","article-title":"Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention","volume":"12","author":"Waybill","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0002","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrneph.2010.116","article-title":"Contrast-induced acute kidney injury and diabetic nephropathy","volume":"6","author":"Calvin","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0003","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/CIRCULATIONAHA.115.014672","article-title":"Contrast-induced nephropathy","volume":"132","author":"Wichmann","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2021.03.005_bib0004","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1681\/ASN.2016010021","article-title":"Estimating the risk of radiocontrast-associated nephropathy","volume":"28","author":"Wilhelm-Leen","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.annemergmed.2016.11.021","article-title":"Risk of acute kidney injury after intravenous contrast media administration","volume":"69","author":"Hinson","year":"2017","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.trsl.2021.03.005_bib0006","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00330-017-5246-5","article-title":"Post-contrast acute kidney injury - Part 1: definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines","volume":"28","author":"van der Molen","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0007","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/ndt\/gfy149","article-title":"Pro: contrast-induced nephropathy-should we try to avoid contrast media in patients with chronic kidney disease?","volume":"33","author":"Windpessl","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2021.03.005_bib0008","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/RLI.0000000000000298","article-title":"Acute kidney injury after intravenous versus intra-arterial contrast material administration in a paired cohort","volume":"51","author":"McDonald","year":"2016","journal-title":"Invest Radiol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0009","doi-asserted-by":"crossref","first-page":"F1210","DOI":"10.1152\/ajprenal.00004.2020","article-title":"Increased fibrotic signaling in a murine model for intra-arterial contrast-induced acute kidney injury","volume":"318","author":"Sharma","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0010","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.jvir.2017.07.038","article-title":"Predictors and outcomes of postcontrast acute kidney injury after endovascular renal artery intervention","volume":"28","author":"Takahashi","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0011","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13054-017-1862-3","article-title":"The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study","volume":"21","author":"Palli","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.trsl.2021.03.005_bib0012","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41598-017-01160-1","article-title":"Efficacy of alprostadil for preventing of contrast-induced nephropathy: a meta-analysis","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2021.03.005_bib0013","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1038\/cddis.2011.38","article-title":"In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis","volume":"2","author":"Quintavalle","year":"2011","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2021.03.005_bib0014","doi-asserted-by":"crossref","first-page":"F1210","DOI":"10.1152\/ajprenal.00004.2020","article-title":"Increased fibrotic signaling in a murine model for intra-arterial contrast induced acute kidney Injury (CI-AKI)","volume":"318(5)","author":"Sharma","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0015","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1038\/s41598-018-24340-z","article-title":"Increased transforming growth factor beta (TGF-\u03b2) and pSMAD3 signaling in a Murine Model for Contrast Induced Kidney Injury","volume":"8","author":"Kilari","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2021.03.005_bib0016","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.RES.78.5.737","article-title":"alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling","volume":"78","author":"Graham","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2021.03.005_bib0017","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3109\/10799899509049862","article-title":"Actions of terazosin and its enantiomers at subtypes of alpha 1- and alpha 2-adrenoceptors in vitro","volume":"15","author":"Hancock","year":"1995","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.trsl.2021.03.005_bib0018","series-title":"Alpha Adrenergic Receptors","author":"Taylor","year":"2020"},{"key":"10.1016\/j.trsl.2021.03.005_bib0019","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jvir.2015.12.751","article-title":"The role of repeat administration of adventitial delivery of lentivirus-shRNA-Vegf-A in arteriovenous fistula to prevent venous stenosis formation","volume":"27","author":"Janardhanan","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0020","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.ymthe.2019.06.011","article-title":"The role of microRNA-21 in venous neointimal hyperplasia: implications for targeting miR-21 for VNH treatment","volume":"27","author":"Kilari","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.trsl.2021.03.005_bib0021","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0022","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1474-8673.2007.00413.x","article-title":"Evidence of alpha1-adrenoceptor functional changes in omental arteries of patients with end-stage renal disease","volume":"28","author":"Cruz-Dominguez","year":"2008","journal-title":"Auton Autacoid Pharmacol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0023","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/jcb.24852","article-title":"High-resolution molecular validation of self-renewal and spontaneous differentiation in clinical-grade adipose-tissue derived human mesenchymal stem cells","volume":"115","author":"Dudakovic","year":"2014","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.trsl.2021.03.005_bib0024","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.trsl.2021.03.005_bib0025","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2021.03.005_bib0026","doi-asserted-by":"crossref","first-page":"11367","DOI":"10.1038\/s41598-017-11309-7","article-title":"Induction of oxidative metabolism by the p38\u03b1\/MK2 pathway","volume":"7","author":"Trempolec","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2021.03.005_bib0027","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/tpj.2016.29","article-title":"Genetic variation in the alpha1B-adrenergic receptor and vascular response","volume":"17","author":"Adefurin","year":"2017","journal-title":"Pharmacogenom J"},{"key":"10.1016\/j.trsl.2021.03.005_bib0028","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.phrs.2010.08.005","article-title":"Endothelin modulates the cardiovascular effects of clonidine in the rat","volume":"62","author":"Lavhale","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.trsl.2021.03.005_bib0029","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/bjp.2008.16","article-title":"Oxidative stress and alpha1-adrenoceptor-mediated stimulation of the Cl-\/HCO3- exchanger in immortalized SHR proximal tubular epithelial cells","volume":"153","author":"Sim\u00e3o","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/jpet.300.1.83","article-title":"\u03b11B- and \u03b11D-adrenergic receptors exhibit different requirements for agonist and mitogen-activated protein kinase activation to regulate growth responses in rat 1 fibroblasts","volume":"300","author":"Waldrop","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.trsl.2021.03.005_bib0031","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.trsl.2021.03.005_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/578974","article-title":"Hemodynamic and tubular changes induced by contrast media","volume":"2014","author":"Caiazza","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.trsl.2021.03.005_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143390","article-title":"Matrix metalloproteinase-2 knockout and heterozygote mice are protected from hydronephrosis and kidney fibrosis after unilateral ureteral obstruction","volume":"10","author":"Tveitaras","year":"2015","journal-title":"PLoS One"},{"issue":"suppl 1","key":"10.1016\/j.trsl.2021.03.005_bib0034","doi-asserted-by":"crossref","first-page":"i37","DOI":"10.1093\/ndt\/gft267","article-title":"Transforming growth factor-beta and the progression of renal disease","volume":"29","author":"Loeffler","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2021.03.005_bib0035","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/eurheartj\/ehr494","article-title":"Contrast-induced kidney injury: mechanisms, risk factors, and prevention","volume":"33","author":"Seeliger","year":"2012","journal-title":"Eur Heart J"},{"issue":"suppl 4","key":"10.1016\/j.trsl.2021.03.005_bib0036","first-page":"S35","article-title":"The use of alpha-blockers for the treatment of nephrolithiasis","volume":"8","author":"Lipkin","year":"2006","journal-title":"Rev Urol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0037","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00005344-198201000-00008","article-title":"Alpha-adrenoceptor blockade by phentolamine causes beta-adrenergic vasodilation by increased catecholamine release due to presynaptic alpha-blockade","volume":"4","author":"Saeed","year":"1982","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0038","first-page":"1555","article-title":"The alpha1-adrenoceptor antagonist terazosin induces prostate cancer cell death through a p53 and Rb independent pathway","volume":"10","author":"Xu","year":"2003","journal-title":"Oncol Rep"},{"key":"10.1016\/j.trsl.2021.03.005_bib0039","first-page":"F1166","article-title":"Differential regulation of renal regional blood flow by endothelin-1","volume":"271","author":"Gurbanov","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.semnephrol.2015.03.004","article-title":"Endothelin and tubulointerstitial renal disease","volume":"35","author":"Ong","year":"2015","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0041","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3389\/fphys.2019.01032","article-title":"Long-term high-altitude hypoxia and alpha adrenoceptor-dependent pulmonary arterial contractions in fetal and adult sheep","volume":"10","author":"Moretta","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.trsl.2021.03.005_bib0042","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.4161\/auto.29456","article-title":"MAPK14\/p38alpha-dependent modulation of glucose metabolism affects ROS levels and autophagy during starvation","volume":"10","author":"Desideri","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.trsl.2021.03.005_bib0043","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/10641960802668730","article-title":"Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease","volume":"31","author":"Friese","year":"2009","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.trsl.2021.03.005_bib0044","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1523-1755.2005.00500.x","article-title":"Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN","volume":"68","author":"Nishitani","year":"2005","journal-title":"Kidney Int"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524421000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524421000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:44:30Z","timestamp":1761828270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524421000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":44,"alternative-id":["S1931524421000554"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2021.03.005","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel therapeutic targets for contrast induced acute kidney injury (CI-AKI): alpha blockers as a therapeutic strategy for CI-AKI","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2021.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}